Chengwen Teng
- Molecular Biology
- Infectious Diseases top 10%
- Immunology
- Pharmacology top 10%
- Epidemiology
- Co-authors
- Christopher R. FreiNatalie K. BoydKelly R. RevelesJie YanQi LiHong‐Bing ShuBo ZhongAiping Mao
- Topics
- Antimicrobial Resistance in Staphylococcus (7 papers)Pharmacovigilance and Adverse Drug Reactions (7 papers)Pharmaceutical studies and practices (4 papers)
- Journals
- Journal of Biological ChemistryBloodAmerican Journal of Physiology-Gastrointestinal and Liver Physiology
- Partner nations
- United StatesJapanChina
In The Last Decade
Chengwen Teng
26 papers receiving 627 citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 208
- Infectious Diseases 122
- Immunology 110
- Pharmacology 108
- Epidemiology 90
Countries citing papers authored by Chengwen Teng
This map shows the geographic impact of Chengwen Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengwen Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengwen Teng more than expected).
Fields of papers citing papers by Chengwen Teng
This network shows the impact of papers produced by Chengwen Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengwen Teng. The network helps show where Chengwen Teng may publish in the future.
Co-authorship network of co-authors of Chengwen Teng
This figure shows the co-authorship network connecting the top 25 collaborators of Chengwen Teng. A scholar is included among the top collaborators of Chengwen Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengwen Teng. Chengwen Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 11 | |
| 5 | 1 | |
| 6 | 23 | |
| 7 | 97 | |
| 8 | 22 | |
| 9 | 15 | |
| 10 | 37 | |
| 11 | 24 | |
| 12 | 37 | |
| 13 | 34 | |
| 14 | 64 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 5 | |
| 18 | 8 | |
| 19 | 12 | |
| 20 | 119 |
About Chengwen Teng
Chengwen Teng is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 27 papers that have together received 638 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (7 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (42 citations), Toxicology (68 citations) and Molecular Medicine (60 citations). Chengwen Teng has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Christopher R. Frei, Natalie K. Boyd, Kelly R. Reveles, Jie Yan, Qi Li, Hong‐Bing Shu, Bo Zhong, Aiping Mao, Ying Li and Shu Li. Their work appears in journals such as Journal of Biological Chemistry, Blood and American Journal of Physiology-Gastrointestinal and Liver Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.